# SILDENAFIL CITRATE
> **ANDA214556** · Abbreviated New Drug Application (Generic) · Sponsor: GRANULES · Approved 2023-12-01
## Drug
- **FDA Application Number:** ANDA214556
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SILDENAFIL CITRATE
- **Generic name:** Sildenafil Citrate
- **Active ingredients:** SILDENAFIL CITRATE
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** GRANULES
- **First approval:** 2023-12-01
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214556)
---
*MORVS · CC0 1.0*